Journal Title：Ageing Research Reviews

As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.

隨著人類平均壽命的增加，衰老和與年齡相關(guān)的疾病對我們社會的影響也隨之增加。衰老研究現(xiàn)在是數(shù)千個實驗室的重點，其中包括遺傳學、分子和細胞生物學、生物化學和行為學領(lǐng)域的領(lǐng)導者。衰老研究評論 (ARR) 涵蓋了該領(lǐng)域的趨勢。它旨在填補一個巨大的空白，即提供有關(guān)衰老和與年齡相關(guān)的疾病機制的新發(fā)現(xiàn)的批判性評論和觀點的來源。對控制細胞增殖、分化和存活的機制的理解迅速取得進展，為衰老的調(diào)節(jié)帶來了新的見解。從端粒酶到干細胞再到能量和氧自由基代謝，這是衰老研究多學科領(lǐng)域令人興奮的新時代。人們正在確定延長壽命的操作（例如熱量限制）的細胞和分子基礎(chǔ)，并正在開發(fā)預防與年齡相關(guān)的疾病的新方法。 ARR 發(fā)表從廣泛的衰老研究領(lǐng)域中精選的重點主題文章，重點關(guān)注衰老過程的細胞和分子機制以及與年齡相關(guān)的疾病，如癌癥、心血管疾病、糖尿病和神經(jīng)退行性疾病。該期刊還涵蓋基礎(chǔ)衰老研究在延長壽命和預防疾病方面的應用。

Ageing Research Reviews創(chuàng)刊于2002年，由Elsevier Ireland Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 老年醫(yī)學全領(lǐng)域，在行業(yè)領(lǐng)域中學術(shù)影響力很大，屬于TOP期刊，國際一流期刊，關(guān)注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關(guān)注此刊。平均審稿速度 約3月 ，影響因子指數(shù)12.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。